Back

CIRRUS-HCM: 12-Week Evaluation of the Safety and Efficacy of the Novel Cardiac Sarcomere Modulator EDG-7500 in Nonobstructive and Obstructive Hypertrophic Cardiomyopathy

31 August 2026 (11:30 - 11:45)
Organised by: Logo
Congress Presentation Part of: Transforming the heart: novel therapies for myocardial disease and heart failure Hypertrophic Cardiomyopathy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Anjali Owens

University of Pennsylvania, Philadelphia (United States of America)

3 More presentations in this session

Presentation thumbnail
Outcomes of Intracoronary AAV1/SERCA2a Gene Therapy in Patients With Heart Failure With Preserved Ejection Fraction: 12-Month Results From the MUSIC-HFpEF Phase 1/2a Trial
Doctor M. Fudim (Durham, US)
Slides Video
Presentation thumbnail
The autoregulated bioprosthetic total artificial heart in advanced biventricular failure: 180-day outcomes from the EFICAS study
Professor A. Vincentelli (Lille, FR)
Slides Video
Presentation thumbnail
Intravenous Dexrazoxane for Hemorrhagic Myocardial Infarction in STEMI: A Double-Blind, Placebo-Controlled, Sequential-Cohort Phase IIa Trial (SHIELD-MI)
Doctor K. Vora (Indianapolis, US)
Slides Video

Access the full session

Session thumbnail
Transforming the heart: novel therapies for myocardial disease and heart failure
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 11:30 CET
You may be interested in
thumbnail
Congress Presentation
CIRRUS­HCM: A multiple-dose phase 2 study of safety, tolerability, and effects on hemodynamics and functional capacity of the novel cardiac sarcomere modulator EDG-7500 in hypertrophic cardiomyopathy
18 May 2025
thumbnail
Congress Presentation
Myosin inhibitors and heart failure
30 August 2026
thumbnail
Congress Presentation
Effect of aficamten on cardiac structure and function in patients with symptomatic nonobstructive hypertrophic cardiomyopathy - Results from the ACACIA-HCM trial
29 August 2026
thumbnail
Congress Presentation
BHB/HRS-1893 in non-obstructive hypertrophic cardiomyopathy
11 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources